{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:44:18Z","timestamp":1792799058158,"version":"4.5.0"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC), Oxford","award":["P2-001"],"award-info":[{"award-number":["P2-001"]}],"id":[{"id":"https:\/\/ror.org\/021954z67","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203921\/Z\/16\/Z"],"award-info":[{"award-number":["203921\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2024,10,3]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) is not included in atrial fibrillation (AF) bleeding risk prediction scores, reflecting uncertainty regarding its importance as a risk factor for major haemorrhage. We aimed to report the relative risk of first major haemorrhage in people with HF and AF compared with people with AF without HF (\u2018AF only\u2019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>English primary care cohort study of 2\u2009178\u2009162 people aged \u226545 years in the Clinical Practice Research Datalink from January 2000 to December 2018, linked to secondary care and mortality databases. We used traditional survival analysis and competing risks methods, accounting for all-cause mortality and anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 7.56 years median follow-up, 60\u2009270 people were diagnosed with HF and AF of whom 4996 (8.3%) had a major haemorrhage and 36\u2009170 died (60.0%), compared with 8256 (6.4%) and 34\u2009375 (27.2%), respectively, among 126\u2009251 people with AF only. Less than half those with AF were prescribed an anticoagulant (45.6% from 2014 onwards), although 75.7% were prescribed an antiplatelet or anticoagulant. In a fully adjusted Cox model, the HR for major haemorrhage was higher among people with HF and AF (2.52, 95% CI 2.44 to 2.61) than AF only (1.87, 95% CI 1.82 to 1.92), even in a subgroup analysis of people prescribed anticoagulation. However, in a Fine and Gray competing risk model, the HR of major haemorrhage was similar for people with AF only (1.82, 95% CI 1.77 to 1.87) or HF and AF (1.71, 95% CI 1.66 to 1.78).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>People with HF and AF are at increased risk of major haemorrhage compared with those with AF only and current prediction scores may underestimate the risk of haemorrhage in HF and AF. However, people with HF and AF are more likely to die than have a major haemorrhage and therefore an individual\u2019s expected prognosis should be carefully considered when predicting future bleeding risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2024-002975","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T22:45:12Z","timestamp":1728945912000},"page":"e002975","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Heart failure and major haemorrhage in people with atrial fibrillation"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-3785","authenticated-orcid":false,"given":"Nicholas R","family":"Jones","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Smith","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"},{"name":"NIHR Oxford Biomedical Research Centre, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lay-Flurrie","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Yang","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-7172","authenticated-orcid":false,"given":"FD Richard","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-2581","authenticated-orcid":false,"given":"Clare J","family":"Taylor","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"},{"name":"Department of Applied Health Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"2025081612161864000_11.2.e002975.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018614"},{"key":"2025081612161864000_11.2.e002975.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"2025081612161864000_11.2.e002975.3","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.15829\/1560-4071-2021-4701","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"26","author":"Hindricks","year":"2020","journal-title":"Russ J Cardiol"},{"key":"2025081612161864000_11.2.e002975.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2025081612161864000_11.2.e002975.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025081612161864000_11.2.e002975.6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00350","article-title":"Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study","volume":"9","author":"Giardina","year":"2018","journal-title":"Front Pharmacol"},{"key":"2025081612161864000_11.2.e002975.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2025081612161864000_11.2.e002975.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"2025081612161864000_11.2.e002975.9","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv476","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O\u2019Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"2025081612161864000_11.2.e002975.10","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1594"},{"key":"2025081612161864000_11.2.e002975.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719"},{"key":"2025081612161864000_11.2.e002975.12","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025081612161864000_11.2.e002975.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019638","article-title":"Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study","volume":"8","author":"Loo","year":"2018","journal-title":"BMJ Open"},{"key":"2025081612161864000_11.2.e002975.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"2025081612161864000_11.2.e002975.15","unstructured":"Stata . stsum- summarize survival-time data."},{"key":"2025081612161864000_11.2.e002975.16","unstructured":"Clayton DG , Hills M . Statistical Models in Epidemiology. Oxford: Oxford University Press, 1993."},{"key":"2025081612161864000_11.2.e002975.17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp107"},{"key":"2025081612161864000_11.2.e002975.18","unstructured":"Clayton P . STCOMLIST: Stata Module to List Cumulative Function in Presence of Competing Risks, Components SS, Ed. Boston College Department of Economics, 2017."},{"key":"2025081612161864000_11.2.e002975.19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8399"},{"key":"2025081612161864000_11.2.e002975.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.957951"},{"key":"2025081612161864000_11.2.e002975.21","unstructured":"National Collaborating Centre for Chronic Conditions (UK) . Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. NICE Clinical Guidelines, No. 36, LRCoPU, Ed. 2006:36."},{"key":"2025081612161864000_11.2.e002975.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.112.972869"},{"key":"2025081612161864000_11.2.e002975.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.024"},{"key":"2025081612161864000_11.2.e002975.24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007230","article-title":"Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation","volume":"14","author":"Jackevicius","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025081612161864000_11.2.e002975.25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487319843069","article-title":"Incidence and subsequent prognostic impacts of gastrointestinal bleeding in patients with heart failure","volume":"27","author":"Yoshihisa","year":"2020","journal-title":"Eur J Prev Cardiolog"},{"key":"2025081612161864000_11.2.e002975.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191592","article-title":"Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation","volume":"13","author":"Bassand","year":"2018","journal-title":"PLoS One"},{"key":"2025081612161864000_11.2.e002975.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4606","article-title":"Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores","volume":"349","author":"Hippisley-Cox","year":"2014","journal-title":"BMJ"},{"key":"2025081612161864000_11.2.e002975.28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004580","article-title":"Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation","volume":"11","author":"Abdel-Qadir","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025081612161864000_11.2.e002975.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j4587","article-title":"Handling time varying confounding in observational research","volume":"359","author":"Mansournia","year":"2017","journal-title":"BMJ"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-002975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:16:29Z","timestamp":1755371789000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-002975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,14]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/openhrt-2024-002975"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-002975","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}